BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31044644)

  • 21. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.
    Crisafulli E; Ielpo A; Barbeta E; Ceccato A; Huerta A; Gabarrús A; Soler N; Chetta A; Torres A
    Respir Res; 2018 Dec; 19(1):261. PubMed ID: 30591055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
    Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD.
    France G; Orme MW; Greening NJ; Steiner MC; Chaplin EJ; Clinch L; Singh SJ
    Respir Med; 2021 Jan; 176():106249. PubMed ID: 33253973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Liu D; Peng SH; Zhang J; Bai SH; Liu HX; Qu JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1265-73. PubMed ID: 26170655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial.
    Rafiq R; Prins HJ; Boersma WG; Daniels JM; den Heijer M; Lips P; de Jongh RT
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2583-2592. PubMed ID: 28894361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-intensity versus low-intensity noninvasive positive pressure ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease (HAPPEN): study protocol for a multicenter randomized controlled trial.
    Luo Z; Wu C; Li Q; Zhu J; Pang B; Shi Y; Ma Y; Cao Z;
    Trials; 2018 Nov; 19(1):645. PubMed ID: 30463622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of High-Dose Vitamin D Replacement on the Serum Levels of Systemic Inflammatory Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Dastan F; Salamzadeh J; Pourrashid MH; Edalatifard M; Eslaminejad A
    COPD; 2019 Aug; 16(3-4):278-283. PubMed ID: 31550915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-body vibration improves functional capacity and quality of life in patients with severe chronic obstructive pulmonary disease (COPD): a pilot study.
    Braz Júnior DS; Dornelas de Andrade A; Teixeira AS; Cavalcanti CA; Morais AB; Marinho PE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():125-32. PubMed ID: 25624756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease.
    Liang Y; Chang C; Zhu H; Shen N; He B; Yao W
    Intern Emerg Med; 2015 Sep; 10(6):685-91. PubMed ID: 25822151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory and peripheral muscle strength influence recovery of exercise capacity after severe exacerbation of COPD? An observational prospective cohort study.
    Heubel AD; Kabbach EZ; Leonardi NT; Schafauser NS; Kawakami DMO; Sentanin AC; Pires Di Lorenzo VA; Borghi Silva A; Hurst JR; Mendes RG
    Heart Lung; 2023; 58():91-97. PubMed ID: 36434827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary rehabilitation for patients with acute chronic obstructive pulmonary disease exacerbations: is the evidence strengthening?
    Spencer L
    Curr Opin Pulm Med; 2018 Mar; 24(2):147-151. PubMed ID: 29210749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examining changes in vascular function, arterial stiffness and systemic inflammation during hospitalization and recovery from an acute exacerbation of chronic obstructive pulmonary disease.
    Fuhr DP; Brotto AR; Rowe BH; Bhutani M; Rosychuk RJ; Stickland MK
    Sci Rep; 2023 Jul; 13(1):12245. PubMed ID: 37507427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
    Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
    Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
    Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
    J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review.
    Qian Y; Cai C; Sun M; Lv D; Zhao Y
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2707-2723. PubMed ID: 38034468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
    Kunisaki KM; Dransfield MT; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Hartley BF; Martinez FJ; Newby DE; Pragman AA; Vestbo J; Yates JC; Niewoehner DE;
    Am J Respir Crit Care Med; 2018 Jul; 198(1):51-57. PubMed ID: 29442524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.
    Cushen B; McCormack N; Hennigan K; Sulaiman I; Costello RW; Deering B
    Respir Med; 2016 Oct; 119():55-62. PubMed ID: 27692148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.